The landscape of dementia prognosis has advanced radically with the arrival of innovative biomarkers, which includes amyloid PET scans, tau imaging, and blood-centered exams that can detect Alzheimer's pathology several years ahead of signs and symptoms arise. Even though these technological advances characterize remarkable development in being familiar with neurodegenerative https://josephp654vht6.azzablog.com/profile